002349 精华制药
已收盘 09-30 15:00:00
资讯
新帖
简况
精华制药（002349）9月29日主力资金净卖出1826.00万元
证券之星 · 09-30 09:11
精华制药（002349）9月29日主力资金净卖出1826.00万元
异动快报：精华制药（002349）9月21日9点56分触及涨停板
证券之星 · 09-21
异动快报：精华制药（002349）9月21日9点56分触及涨停板
精华制药：外敷水凝胶已完成小试工作
证券之星 · 09-18
精华制药：外敷水凝胶已完成小试工作
股市必读：精华制药（002349）9月11日董秘有最新回复
证券之星 · 09-14
股市必读：精华制药（002349）9月11日董秘有最新回复
精华制药：公司目前暂未生产该产品
证券之星 · 09-11
精华制药：公司目前暂未生产该产品
股市必读：精华制药新发布《关于公司董事辞职的公告》
证券之星 · 09-11
股市必读：精华制药新发布《关于公司董事辞职的公告》
精华制药（002349）披露股票交易异常波动公告，9月10日股价下跌8.1%
证券之星 · 09-10
精华制药（002349）披露股票交易异常波动公告，9月10日股价下跌8.1%
2连板精华制药：股票交易异常波动不存在应披露未披露事项
证券之星 · 09-09
2连板精华制药：股票交易异常波动不存在应披露未披露事项
9月9日精华制药（002349）龙虎榜数据：机构净卖出55.27万元（3日），北向资金净买入5819.77万元（3日）
证券之星 · 09-09
9月9日精华制药（002349）龙虎榜数据：机构净卖出55.27万元（3日），北向资金净买入5819.77万元（3日）
股市必读：精华制药（002349）8月28日披露最新机构调研信息
证券之星 · 08-31
股市必读：精华制药（002349）8月28日披露最新机构调研信息
精华制药：8月28日召开业绩说明会，投资者参与
证券之星 · 08-28
精华制药：8月28日召开业绩说明会，投资者参与
中药板块盘中拉升 精华制药股价涨停
证券之星 · 08-28
中药板块盘中拉升 精华制药股价涨停
股市必读：精华制药中报 - 第二季度单季净利润同比增长2.67%
证券之星 · 08-28
股市必读：精华制药中报 - 第二季度单季净利润同比增长2.67%
精华制药（002349）2026年中报简析：营收净利润同比双双增长，盈利能力上升
证券之星 · 08-28
精华制药（002349）2026年中报简析：营收净利润同比双双增长，盈利能力上升
精华制药(002349)6月30日股东户数7.65万户，较上期减少5.25%
证券之星 · 08-27
精华制药(002349)6月30日股东户数7.65万户，较上期减少5.25%
精华制药(002349.SZ)发布半年度业绩，归母净利润1.36亿元，同比增长4.2%
智通财经 · 08-26
精华制药(002349.SZ)发布半年度业绩，归母净利润1.36亿元，同比增长4.2%
精华制药（002349）披露2026年半年度报告，8月26日股价上涨1.0%
证券之星 · 08-26
精华制药（002349）披露2026年半年度报告，8月26日股价上涨1.0%
股市必读：精华制药（002349）8月25日董秘有最新回复
证券之星 · 08-26
股市必读：精华制药（002349）8月25日董秘有最新回复
股市必读：精华制药（002349）8月14日董秘有最新回复
证券之星 · 08-17
股市必读：精华制药（002349）8月14日董秘有最新回复
股市必读：精华制药（002349）7月30日董秘有最新回复
证券之星 · 07-31
股市必读：精华制药（002349）7月30日董秘有最新回复
暂无数据
公司概况
公司名称：
精华制药集团股份有限公司
所属行业：
医药制造业
上市日期：
2010-02-03
主营业务：
精华制药集团股份有限公司的主营业务是传统中成药制剂、化学原料药及中间体、化工医药中间体、中药材及中药饮片、大健康产品等的研发、生产和销售。公司的主要产品是王氏保赤丸、季德胜蛇药片、正柴胡饮颗粒、黄芪泡腾片、当归、白芍、苯巴比妥、氟尿嘧啶、二氧六环、甲基肼。
发行价格：
19.80
{"stockData":{"symbol":"002349","market":"SZ","secType":"STK","nameCN":"精华制药","latestPrice":8.55,"timestamp":1790751795000,"preClose":8.37,"halted":0,"volume":61500089,"delay":0,"changeRate":0.0215,"floatShares":814000000,"shares":831000000,"eps":0.2705,"marketStatus":"已收盘","change":0.18,"latestTime":"09-30 15:00:00","open":8.44,"high":8.7,"low":8.39,"amount":526000000,"amplitude":0.037,"askPrice":8.56,"askSize":1205,"bidPrice":8.55,"bidSize":3457,"shortable":0,"etf":0,"ttmEps":0.2705,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1791423000000},"marketStatusCode":5,"adr":0,"adjPreClose":8.37,"symbolType":"stock","openAndCloseTimeList":[[1790731800000,1790739000000],[1790744400000,1790751600000]],"highLimit":9.21,"lowLimit":7.53,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":831128308,"isCdr":false,"pbRate":2.46,"roa":"--","peRate":31.608133,"roe":"4.84%","epsLYR":0.2678,"committee":-0.026955,"marketValue":7106000000,"turnoverRate":0.0755,"status":0,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-10-08。","floatMarketCap":6961000000},"requestUrl":"/m/hq/s/002349/tweets","defaultTab":"tweets","newsList":[{"id":"2671422627","title":"精华制药（002349）9月29日主力资金净卖出1826.00万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2671422627","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671422627?lang=zh_cn&edition=full","pubTime":"2026-09-30 09:11","pubTimestamp":1790730718,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年9月29日收盘，精华制药报收于8.37元，下跌3.57%，换手率7.68%，成交量62.57万手，成交额5.33亿元。9月29日的资金流向数据方面，主力资金净流出1826.0万元，占总成交额3.43%，游资资金净流入2045.6万元，占总成交额3.84%，散户资金净流出219.59万元，占总成交额0.41%。融券方面，融券卖出1300.0股，融券偿还0.0股，融券余量4.62万股，融券余额38.67万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000007675.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002349","BK0239","BK0102"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669139336","title":"异动快报：精华制药（002349）9月21日9点56分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2669139336","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669139336?lang=zh_cn&edition=full","pubTime":"2026-09-21 10:01","pubTimestamp":1789956082,"startTime":"0","endTime":"0","summary":"证券之星9月21日盘中消息，9点56分精华制药（002349）触及涨停板。其所属行业中药目前上涨。领涨股为精华制药。该股为PD-1抑制剂，流感，化学原料药概念热股，当日PD-1抑制剂概念上涨3.3%，流感概念上涨2.82%，化学原料药概念上涨2.22%。9月18日的资金流向数据方面，主力资金净流出640.17万元，占总成交额1.18%，游资资金净流出1275.25万元，占总成交额2.35%，散户资金净流入1915.42万元，占总成交额3.54%。近5日资金流向一览见下表：精华制药主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092100004710.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","BK0239","002349"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668847943","title":"精华制药：外敷水凝胶已完成小试工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2668847943","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668847943?lang=zh_cn&edition=full","pubTime":"2026-09-18 15:03","pubTimestamp":1789714990,"startTime":"0","endTime":"0","summary":"投资者提问：建议公司对季德胜蛇药片进行剂型改革，推出一些外用膏剂水剂型季德胜蛇药产品精华制药回复：您好，公司已围绕外用剂型开展了一系列研发布局：外敷水凝胶已完成小试工作，该产品利用水凝胶作为药物缓释和生物活性物质递送的载体，联合季德胜蛇药片等产品外敷治疗带状疱疹等疾病，旨在为片剂外用提供更便利的使用方式与更好的体验。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091800018290.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002349","BK0102"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667870086","title":"股市必读：精华制药（002349）9月11日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2667870086","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667870086?lang=zh_cn&edition=full","pubTime":"2026-09-14 01:12","pubTimestamp":1789319532,"startTime":"0","endTime":"0","summary":"截至2026年9月11日收盘，精华制药报收于8.01元，下跌5.88%，换手率10.91%，成交量88.79万手，成交额7.14亿元。董秘最新回复投资者： 董秘您好，查阅公开药品信息，公司持有盐酸多西环素片注册文号，该药品说明书注明可作为青霉素过敏患者部分感染的替代治疗用药。当日关注点交易信息汇总：9月11日主力资金净流出2440.11万元，占总成交额3.42%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091400000503.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002349","BK0102"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666635541","title":"精华制药：公司目前暂未生产该产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2666635541","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666635541?lang=zh_cn&edition=full","pubTime":"2026-09-11 15:03","pubTimestamp":1789110193,"startTime":"0","endTime":"0","summary":"证券之星消息，精华制药(002349)09月11日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，查阅公开药品信息，公司持有盐酸多西环素片注册文号，该药品说明书注明可作为青霉素过敏患者部分感染的替代治疗用药。请问该产品目前是否正常生产？谢谢。精华制药回复：公司目前暂未生产该产品，感谢您对公司的关心！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：沈彬","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091100028352.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002349","BK0102"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666220597","title":"股市必读：精华制药新发布《关于公司董事辞职的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2666220597","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666220597?lang=zh_cn&edition=full","pubTime":"2026-09-11 01:22","pubTimestamp":1789060935,"startTime":"0","endTime":"0","summary":"公司公告汇总关于公司董事辞职的公告精华制药集团股份有限公司收到第六届董事会成员曹伟东先生书面辞职报告。曹伟东先生因个人职业规划原因，申请辞去公司非独立董事职务，辞职后不再担任公司及子公司任何职务。关于股票交易异常波动的公告精华制药集团股份有限公司股票于2026年9月8日、9月9日连续两个交易日收盘价格涨幅偏离值累计超过20%，构成异常波动。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091100002168.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002349","BK0102","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666561478","title":"精华制药（002349）披露股票交易异常波动公告，9月10日股价下跌8.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2666561478","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666561478?lang=zh_cn&edition=full","pubTime":"2026-09-10 17:31","pubTimestamp":1789032713,"startTime":"0","endTime":"0","summary":"截至2026年9月10日收盘，精华制药报收于8.51元，较前一交易日下跌8.1%，最新总市值为70.73亿元。该股当日开盘9.0元，最高9.0元，最低8.36元，成交额达12.01亿元，换手率为17.05%。精华制药于2026年9月10日披露《关于股票交易异常波动的公告》。公告显示，公司股票于2026年9月8日、9月9日连续两个交易日收盘价格涨幅偏离值累计超过20%，构成异常波动。董事会确认不存在应披露而未披露的重大事项，公司不存在违反公平信息披露规定的情形。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091000031567.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002349","BK0239","BK0102"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666581271","title":"2连板精华制药：股票交易异常波动不存在应披露未披露事项","url":"https://stock-news.laohu8.com/highlight/detail?id=2666581271","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666581271?lang=zh_cn&edition=full","pubTime":"2026-09-09 17:49","pubTimestamp":1788947380,"startTime":"0","endTime":"0","summary":"精华制药(002349.SZ)公告称，公司股票于2026年9月8日、9月9日连续两个交易日收盘价格涨幅偏离值累计超过20%，属于股票异常波动情形。经自查，公司前期披露信息不存在需更正补充之处，未发现媒体报道未公开重大信息，近期经营情况及内外部环境未发生重大变化，控股股东不存在应披露未披露事项，且在异常波动期间未买卖公司股票。公司董事会确认目前不存在应披露而未披露的事项。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090900030504.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002349","BK0102","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666818945","title":"9月9日精华制药（002349）龙虎榜数据：机构净卖出55.27万元（3日），北向资金净买入5819.77万元（3日）","url":"https://stock-news.laohu8.com/highlight/detail?id=2666818945","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666818945?lang=zh_cn&edition=full","pubTime":"2026-09-09 17:32","pubTimestamp":1788946324,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2026年9月9日公布的交易公开信息显示，精华制药因连续三个交易日内，涨幅偏离值累计达到20%的证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2026年9月9日收盘，精华制药报收于9.26元，上涨9.98%，已连续涨停2天，换手率14.97%，成交量121.89万手，成交额10.84亿元。从龙虎榜公布的三日买卖数据来看，机构合计净卖出55.27万元，北向资金合计净买入5819.77万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090900029618.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","BK0239","002349"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663042544","title":"股市必读：精华制药（002349）8月28日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2663042544","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663042544?lang=zh_cn&edition=full","pubTime":"2026-08-31 00:37","pubTimestamp":1788107829,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘，精华制药报收于7.89元，上涨10.04%，涨停，换手率5.19%，成交量42.29万手，成交额3.26亿元。当日关注点交易信息汇总：8月28日主力资金净流入1.36亿元，占总成交额41.79%。机构调研要点：2026年上半年“五朵金花”销售平稳，其中季德胜蛇药片收入同比增长30%。截至2026年6月30日，公司普通股股东总数为76,482户。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100000466.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002349","BK0239","BK0102"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662006023","title":"精华制药：8月28日召开业绩说明会，投资者参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2662006023","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662006023?lang=zh_cn&edition=full","pubTime":"2026-08-28 20:02","pubTimestamp":1787918528,"startTime":"0","endTime":"0","summary":"证券之星消息，2026年8月28日精华制药发布公告称公司于2026年8月28日召开业绩说明会。带状疱疹高发于中老年及免疫低下人群，易遗留后遗神经痛，临床需求旺盛，市场空间较大。公司相关推广上，首要推进带状疱疹适应症申报，争取载入药品说明书。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800048640.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0102","002349"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662599200","title":"中药板块盘中拉升 精华制药股价涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2662599200","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662599200?lang=zh_cn&edition=full","pubTime":"2026-08-28 13:49","pubTimestamp":1787896155,"startTime":"0","endTime":"0","summary":"8月28日，中药板块盘中拉升。个股方面，截至发稿，精华制药股价涨停。消息面上值得关注的是8月26日，精华制药公布2026年中报。从业务结构看，公司收入主要来源于中药制剂、化工医药中间体及化学原料药。公司同日披露的《关于“十五五”战略规划的公告》显示，公司将从“双轮驱动”向“中成药产业、原料药产业、大健康产业”的“三驾马车”发展格局转变，聚焦做优中药、做精化学原料药及制剂、拓展大健康。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2026082800028780.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0102","002349"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662321280","title":"股市必读：精华制药中报 - 第二季度单季净利润同比增长2.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662321280","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662321280?lang=zh_cn&edition=full","pubTime":"2026-08-28 08:41","pubTimestamp":1787877702,"startTime":"0","endTime":"0","summary":"截至2026年8月27日收盘，精华制药报收于7.17元，上涨1.41%，换手率2.11%，成交量17.15万手，成交额1.23亿元。股本股东变化：截至2026年6月30日股东户数为7.65万户，较3月31日减少5.25%，户均持股增至1.09万股。业绩披露要点：2026年上半年主营收入7.55亿元，归母净利润1.36亿元，毛利率54.26%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800016023.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002349"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662203965","title":"精华制药（002349）2026年中报简析：营收净利润同比双双增长，盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2662203965","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662203965?lang=zh_cn&edition=full","pubTime":"2026-08-28 06:27","pubTimestamp":1787869643,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期精华制药发布2026年中报。截至本报告期末，公司营业总收入7.55亿元，同比上升3.19%，归母净利润1.36亿元，同比上升4.2%。按单季度数据看，第二季度营业总收入3.75亿元，同比上升1.94%，第二季度归母净利润7025.29万元，同比上升2.67%。本报告期精华制药盈利能力上升，毛利率同比增幅1.21%，净利率同比增幅5.57%。去年的净利率为17.93%，算上全部成本后，公司产品或服务的附加值高。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800011369.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002349"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662703510","title":"精华制药(002349)6月30日股东户数7.65万户，较上期减少5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662703510","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662703510?lang=zh_cn&edition=full","pubTime":"2026-08-27 18:08","pubTimestamp":1787825316,"startTime":"0","endTime":"0","summary":"证券之星消息，近日精华制药披露，截至2026年6月30日公司股东户数为7.65万户，较3月31日减少4238.0户，减幅为5.25%。在中药行业个股中，精华制药股东户数高于行业平均水平，截至6月30日，中药行业平均股东户数为5.18万户。从股价来看，2026年3月31日至2026年6月30日，精华制药区间跌幅为14.06%，在此期间股东户数减少4238.0户，减幅为5.25%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700043250.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002349","BK0239","BK0102"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662748057","title":"精华制药(002349.SZ)发布半年度业绩，归母净利润1.36亿元，同比增长4.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662748057","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662748057?lang=zh_cn&edition=full","pubTime":"2026-08-26 23:20","pubTimestamp":1787757621,"startTime":"0","endTime":"0","summary":"智通财经APP讯，精华制药(002349.SZ)发布2026年半年度报告，报告期内，公司实现营业收入7.55亿元，同比增长3.19%;归属于上市公司股东的净利润1.36亿元，同比增长4.2%;归属于上市公司股东的扣除非经常性损益的净利润1.32亿元，同比增长3.92%;基本每股收益0.1672元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1486582.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002349"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662710598","title":"精华制药（002349）披露2026年半年度报告，8月26日股价上涨1.0%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662710598","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662710598?lang=zh_cn&edition=full","pubTime":"2026-08-26 22:16","pubTimestamp":1787753769,"startTime":"0","endTime":"0","summary":"近日，精华制药集团股份有限公司披露《2026年半年度报告》。报告显示，本报告期营业收入为754,772,245.25元，较上年同期增长3.19%；归属于上市公司股东的净利润为136,125,439.12元，同比增长4.20%；扣除非经常性损益后的净利润为131,591,232.23元，同比增长3.92%。报告期内，公司实施股权激励预留股份授予，于2026年5月12日完成增发和登记，涉及核心管理人员、技术骨干及业务精英共18人，授予股票数量145.34万股，占授予时公司总股本的0.18%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082600052506.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0102","002349"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662754512","title":"股市必读：精华制药（002349）8月25日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2662754512","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662754512?lang=zh_cn&edition=full","pubTime":"2026-08-26 03:44","pubTimestamp":1787687059,"startTime":"0","endTime":"0","summary":"截至2026年8月25日收盘，精华制药报收于7.0元，上涨2.79%，换手率1.72%，成交量13.98万手，成交额9681.55万元。董秘最新回复投资者： 董秘您好，请问截至8月20日公司股东人数是多少？当日关注点交易信息汇总：8月25日主力资金净流出881.83万元，占总成交额9.11%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082600006174.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0102","002349"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660704431","title":"股市必读：精华制药（002349）8月14日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2660704431","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660704431?lang=zh_cn&edition=full","pubTime":"2026-08-17 02:25","pubTimestamp":1786904715,"startTime":"0","endTime":"0","summary":"截至2026年8月14日收盘，精华制药报收于7.15元，上涨0.99%，换手率2.66%，成交量21.67万手，成交额1.54亿元。董秘最新回复投资者： 请在公司邮箱中及时回复投资者关于股东人数的问题，谢谢董秘： 您的邮件已收到，请您提供完整的信息，供我们核查。当日关注点交易信息汇总：8月14日主力资金净流出372.94万元，占总成交额2.41%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081700000900.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","BK0239","002349"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655698800","title":"股市必读：精华制药（002349）7月30日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2655698800","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655698800?lang=zh_cn&edition=full","pubTime":"2026-07-31 02:28","pubTimestamp":1785436093,"startTime":"0","endTime":"0","summary":"截至2026年7月30日收盘，精华制药报收于6.71元，下跌0.45%，换手率1.15%，成交量9.36万手，成交额6323.86万元。董秘最新回复投资者： 贵司现代化基地还有没有打算建设？也不进行公告进展情况。感谢您对公司的关心!当日关注点交易信息汇总：7月30日主力资金净流出122.88万元，占总成交额1.94%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026073100001803.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002349","BK0102","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1790895192409,"stockEarnings":[{"period":"1week","weight":-0.0023},{"period":"1month","weight":0.125},{"period":"3month","weight":0.3276},{"period":"6month","weight":0.1688},{"period":"1year","weight":0.2114},{"period":"ytd","weight":0.193}],"compareEarnings":[{"period":"1week","weight":-0.024},{"period":"1month","weight":-0.0362},{"period":"3month","weight":-0.0463},{"period":"6month","weight":-0.0098},{"period":"1year","weight":-0.0105},{"period":"ytd","weight":-0.0319}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"精华制药集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"76482人(较上一季度减少5.25%)","perCapita":"10645股","listingDate":"2010-02-03","address":"江苏省南通市崇川区港闸经济开发区兴泰路9号","registeredCapital":"83112万元","survey":" 精华制药集团股份有限公司的主营业务是传统中成药制剂、化学原料药及中间体、化工医药中间体、中药材及中药饮片、大健康产品等的研发、生产和销售。公司的主要产品是王氏保赤丸、季德胜蛇药片、正柴胡饮颗粒、黄芪泡腾片、当归、白芍、苯巴比妥、氟尿嘧啶、二氧六环、甲基肼。","listedPrice":19.8},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"精华制药(002349)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供精华制药(002349)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"精华制药,002349,精华制药股票,精华制药股票老虎,精华制药股票老虎国际,精华制药行情,精华制药股票行情,精华制药股价,精华制药股市,精华制药股票价格,精华制药股票交易,精华制药股票购买,精华制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"精华制药(002349)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供精华制药(002349)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}